Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial
Vaccine (2023) - Comments
pubmed: 37080829  doi: 10.1016/j.vaccine.2023.04.029  issn: 0264-410x  issn: 1873-2518 

Lila Estephan, Ying-Chin Lin, Yi-Tsung Lin, Yen-Hsu Chen, Sung-Ching Pan, Szu-Min Hsieh, Paal Fure Torkehagen, Yi-Jen Weng, Hao-Yuan Cheng, Josue Antonio Estrada, Alexander Waits, Charles Chen, Chia En Lien